Acadia Healthcare Company, Inc. (ACHC) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. Acadia Healthcare is a leading publicly traded pure-play provider of behavioral healthcare services in the U.S., operating 260 facilities with approximately 11,300 beds across 38 states and Puerto Rico. The company provides acute inpatient psychiatric care, specialty treatment, comprehensive treatment centers (CTCs), and residential treatment services.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | YTD 9M 2024 | YTD 9M 2023 |
|---|---|---|---|---|
| Revenue | $815.6 million | $750.3 million | $2,379.7 million | $2,185.9 million |
| Net Income (Attributable to ACHC) | $68.1 million | ($217.7 million) Loss | $223.0 million | ($79.4 million) Loss |
| Diluted EPS | $0.74 | ($2.39) | $2.42 | ($0.87) |
| Operating Cash Flow (YTD) | $13.0 million | $346.0 million | $13.0 million | $346.0 million |
| Total Debt (Long-term + Current) | $1.88 billion | $1.37 billion | $1.88 billion | $1.37 billion |
| Cash and Equivalents | $82.1 million | $99.6 million | $82.1 million | $99.6 million |
Margins: Net income margin for Q3 2024 was approximately 8.4%. The company reported an Adjusted EBITDA margin improvement of 40 basis points for the quarter and 50 basis points year-to-date compared to the prior year.
Material Changes vs. Prior Period
- Profitability Turnaround: The company returned to profitability in Q3 2024 ($68.1M net income) compared to a significant loss in Q3 2023 ($217.7M). The prior year loss was heavily impacted by a $394.2 million legal settlement expense related to the Desert Hills Litigation, which did not recur in Q3 2024.
- Revenue Growth: Revenue increased 8.7% quarter-over-quarter and 8.9% year-to-date, driven by same-facility revenue growth of 8.6% (Q3) and 8.7% (YTD). This growth was fueled by a 3.6% increase in revenue per patient day and a 4.7% increase in patient days.
- Debt Expansion: Total debt increased significantly due to the incurrence of $350 million in Incremental Term Loans in January 2024 and additional borrowings on the revolving credit facility. Interest expense rose to $29.9 million in Q3 2024 from $20.7 million in Q3 2023.
- Cash Flow Volatility: Operating cash flow for the nine months ended September 30, 2024, dropped to $13.0 million from $346.0 million in the prior year. This decrease was primarily due to a $404.9 million net decrease in accounts payable and other accrued liabilities, largely driven by the payment of the $400 million Desert Hills settlement in January 2024.
- Capital Expenditures: Investing cash outflows increased to $533.1 million (YTD 2024) from $287.1 million (YTD 2023), primarily due to $486.9 million in capital expenditures (including $415.6 million for expansion) and $53.6 million for acquisitions.
Guidance, Outlook, Risks, and Unusual Items
- Legal Proceedings & Settlements:
- Desert Hills Litigation: The company paid $400 million in January 2024 to resolve the Inman Litigation and related cases. A sixth lawsuit was filed in October 2024; the company states it cannot quantify the ultimate liability at this time.
- Government Investigations: The company settled the "2017 OIG/DOJ Investigation" for $19.9 million (paid $16.7 million in October 2024, with $3.2 million remaining). Additionally, the company is cooperating with ongoing investigations by the DOJ Criminal Division and the SEC regarding admissions, length of stay, and billing practices.
- Securities Litigation: Two new putative class action complaints were filed in October 2024 alleging violations of the Securities Exchange Act.
- Impairment Charges: The company recorded $10.5 million in non-cash impairment charges in Q3 2024 related to closed facilities (property and lease assets).
- Outlook: Management expects to continue growing through five pathways: expansions, joint ventures, de novo facilities, acquisitions, and continuum of care expansion. They anticipate navigating a tight labor market with wage inflation but note stability in labor costs as a percentage of revenue.
- Risks: Key risks include the outcome of pending litigation and government investigations, regulatory changes affecting Medicaid eligibility, labor shortages, and the impact of interest rate volatility on debt service.
Investor Verification Checklist
- Settlement Reserves: Verify the status of the $3.2 million remaining payment for the 2017 OIG/DOJ settlement and the potential exposure from the sixth Desert Hills lawsuit filed in October 2024.
- Government Investigations: Monitor the progress of the DOJ Criminal Division and SEC investigations regarding billing practices and length of stay, as these could result in further penalties or corporate integrity agreements.
- Debt Covenants: Confirm continued compliance with the Credit Facility's financial covenants (consolidated total net leverage ratio not to exceed 4.5:1.0 and interest coverage ratio of at least 3.0:1.0) given the increased debt load.
- Cash Flow Sustainability: Assess the sustainability of operating cash flows given the significant drop in YTD 2024 compared to 2023, driven by the timing of large liability payments.
- Capital Expenditure ROI: Evaluate the return on the $415.6 million in expansion capital expenditures and the integration of the Turning Point Centers acquisition.